InvestLog
ARWR logo

ARWR

Arrowhead Pharmaceuticals, Inc.NASDAQHealthcare
$61.03-3.00%ClosedMarket Cap: $8.55B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-25HC Wainwright & Co.—Buy—
2026-02-10HC Wainwright & Co.—Buy—
2026-01-22B. Riley Securities—Buy—
2026-01-13Piper Sandler—Overweight—
2026-01-07Goldman Sachs—Neutral—
2026-01-07Chardan Capital—Buy—
2026-01-07Morgan Stanley—Equal Weight—
2025-12-11RBC Capital—Outperform—
2025-12-09B of A Securities—Buy—
2025-12-02HC Wainwright & Co.—Buy—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Thu Sep 30$-4.08$317.7M9
Sat Sep 30$-2.81$548.6M7
Sun Sep 30$-1.27$886.5M2
Mon Sep 30$3.01$1.62B5